Results 131 to 140 of about 46,930 (188)
Google searches show persistent use of outdated terminology for angioedema in Germany
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Sophia Neisinger +3 more
wiley +1 more source
The SKINERGY study will investigate six immune‐mediated inflammatory skin diseases through a nationwide collaboration across all Dutch university medical centres. Involving 720 patients and 120 healthy volunteers, it is aimed at generating a high‐quality dataset to identify biomarkers that enable personalized treatment strategies and improved disease ...
N. G. Koster +68 more
wiley +1 more source
Chronic spontaneous urticaria as an autoimmune feature in common variable immunodeficiency. [PDF]
Korevaar ECA, Karim AF, Dalm VASH.
europepmc +1 more source
OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders
OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta +4 more
wiley +1 more source
Pressure urticaria after fractional radiofrequency microneedling: A case report and practical prevention strategy. [PDF]
Luca SP, Ouiame A.
europepmc +1 more source
Pathophysiology and emerging treatments for dermographic, cholinergic and cold urticaria
This review illustrates key proposed mast cell‐mediated activation pathways in dermographic, cholinergic and cold urticaria, highlighting IgE‐dependent and ‐independent mechanisms. These pathways are increasingly targeted by emerging drugs, aiming to interrupt mast cell activation and mediator release, offering more precise, mechanism‐based treatment ...
Mojca Bizjak‐Suran +2 more
wiley +1 more source
Remibrutinib (Rhapsido) for chronic spontaneous urticaria. [PDF]
Lamkin EN, Bravo E, Taylor J.
europepmc +1 more source
The worldwide burden of skin diseases: Lessons from the Global Burden of Disease data
Skin diseases are a major public health concern worldwide, causing significant personal, economic and social burdens. The Global Burden of Disease (GBD) initiative provides valuable insights but underestimates the burden of skin diseases, emphasizing the urgent need for improved data collection and global collaboration among stakeholders.
Luigi Naldi +16 more
wiley +1 more source
Recall urticaria caused by vedolizumab: case report and literature review. [PDF]
Kozuma M +4 more
europepmc +1 more source
This systematic review included 38 studies assessing substance‐related and behavioural addictions in patients with chronic inflammatory skin diseases. Nicotine and alcohol use were the most frequently reported addictive behaviours. Addictions were associated with increased disease severity, impaired treatment outcomes and greater psychosocial burden ...
Enya Müller +5 more
wiley +1 more source

